BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25385818)

  • 1. Analysis of IGF(CA)19 and IGFBP3-202A/C gene polymorphisms in patients with acromegaly: association with clinical presentation and response to treatments.
    Ramos-Leví AM; Marazuela M; Paniagua A; Quinteiro C; Riveiro J; Álvarez-Escolá C; Lúcas T; Blanco C; de Miguel P; Martínez de Icaya P; Pavón I; Bernabeu I
    Eur J Endocrinol; 2015 Feb; 172(2):115-22. PubMed ID: 25385818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly.
    Sala E; Filopanti M; Ferrante E; Barbieri AM; Malchiodi E; Verrua E; Giavoli C; Lania AG; Arosio M; Beck-Peccoz P; Spada A; Mantovani G
    Eur J Clin Invest; 2014 Dec; 44(12):1222-9. PubMed ID: 25370837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly.
    Jallad RS; Trarbach EB; Duarte FH; Jorge AA; Bronstein MD
    Pituitary; 2015 Oct; 18(5):666-73. PubMed ID: 25552351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.
    Costalonga EF; Antonini SR; Guerra G; Coletta RR; Franca MM; Braz AF; Mendonca BB; Arnhold IJ; Jorge AA
    Pharmacogenomics J; 2012 Oct; 12(5):439-45. PubMed ID: 21468024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
    Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
    Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of polymorphisms in genes encoding for insulin-like growth factor (IGF)-I, insulin, and IGF-binding protein (IGFBP)-3 on IGF-I, IGF-II, and IGFBP-3 levels in umbilical cord plasma.
    Landmann E; Kollerits B; Kreuder JG; Blum WF; Kronenberg F; Rudloff S
    Horm Res Paediatr; 2012; 77(6):341-50. PubMed ID: 22739332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly.
    Akin F; Turgut S; Cirak B; Kursunluoglu R
    Growth Horm IGF Res; 2010 Dec; 20(6):399-403. PubMed ID: 20920870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
    Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
    Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly.
    Kamenicky P; Dos Santos C; Espinosa C; Salenave S; Galland F; Le Bouc Y; Maison P; Bougnères P; Chanson P
    Eur J Endocrinol; 2009 Aug; 161(2):231-5. PubMed ID: 19439509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
    Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
    Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.
    Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T
    Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between acromegaly and a single nucleotide polymorphism (rs2854744) in the IGFBP3 gene.
    Gao M; Zhu B; Xu Z; Liu S; Liu J; Zhang G; Gao Y; Fan Y; Kang X
    BMC Med Genet; 2018 Oct; 19(1):182. PubMed ID: 30290787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.
    Bianchi A; Giustina A; Cimino V; Pola R; Angelini F; Pontecorvi A; De Marinis L
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2015-22. PubMed ID: 19336510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite polymorphism in the P1 promoter region of the IGF‑1 gene is associated with endometrial cancer.
    Kwasniewski W; Gozdzicka-Jozefiak A; Wolun-Cholewa M; Polak G; Sierocinska-Sawa J; Kwasniewska A; Kotarski J
    Mol Med Rep; 2016 Jun; 13(6):4950-8. PubMed ID: 27121258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the
    Gao M; Zhu B; Li P; Zhang G; Chen K; Lv H; Ma R; Zhang L; Fan Y; Kang X
    Front Endocrinol (Lausanne); 2018; 9():751. PubMed ID: 30619084
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene Expression Signature in Adipose Tissue of Acromegaly Patients.
    Hochberg I; Tran QT; Barkan AL; Saltiel AR; Chandler WF; Bridges D
    PLoS One; 2015; 10(6):e0129359. PubMed ID: 26087292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU; Post KD; Powell JS; Wardlaw SL
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
    Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
    Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.